The National Comprehensive Cancer Network clinical practice guidelines suggest possible adjuvant chemotherapy omission for non-myoinvasive stage IC serous endometrial cancers if pelvic cytologic testing shows no malignant cells.
Given the limited available data to support this recommendation, this study examined the association between adjuvant chemotherapy omission and survival in patients with cytology-negative, non-myoinvasive stage IC serous endometrial cancers.
